Agios Pharma (AGIO) Posts Wider Q3 Loss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. RTX
9. S
10. COF

Go back to Agios Pharma (AGIO) Posts Wider Q3 Loss

Agios Pharma (AGIO) Releases Initial AG-120 Data; Oppenheimer Reiterates Perform

November 9, 2015 9:28 AM EST

Oppenheimer reiterated a Perform rating on Agios Pharma (NASDAQ: AGIO) following initial data from an ongoing phase I trial of AG-120. AG-120 was generally well tolerated in advanced solid tumors including glioma, IHCC and chondrosarcoma, with no dose-limiting toxicities (DLTs) observed based on the... More